Epigenica Appoints New Board Members

Epigenica is very pleased to announce the appointment of four new esteemed members to our Board of Directors. Anders Nordström, Eva Walde, Stina Wallmark and Professor Yang Shi bring invaluable expertise from both pioneering science, innovation development and business growth.

Anders Nordström:

• Other current positions: Chairman of the Board at FenoMark Diagnostics, Moleculent and Offspring Biosciences AB. Partner at Colibri Ventures.

• Previous positions: Executive Vice President at Pharmacia, Board Member and CFO at Phadia AB, Board Member Halo Genomics AB, VP Finance & Operations at ArthroCare International.

Eva Walde​:

• Other current positions: Board Member, Co-owner and Investor at Scale Up Life Science Invest, Board Member at FrostPharma AB, Board Member at Sedana Medical.

• Previous positions: Vice President Marketing at Olink Proteomics, VP Commercial Operations International Region at Thermo Fisher Scientific, Global Brand Director at Phadia AB, Strategic Development Manager at Pfizer.

Yang Shi​:

• Other current positions: Professor of Epigenetics at the University of Oxford

• Previous positions: Professor of Cell Biology and C. H. Waddington Professor of Pediatrics at Harvard Medical School, Professor of Pediatrics at Division of Newborn Medicine at Boston Children’s Hospital, Postdoc at Princeton University.